Article Sidebar

PDF
Date Published: 15/02/2023
Abstract Views: 141
Views PDF: 74
DOI: https://doi.org/10.51298/vmj.v521i2.4053
Issue
Vol. 521 No. 2 (2022)
Section
Các bài báo
How to Cite
Lê, T. Đức, & Nguyễn, T. L. L. (2023). CLINICAL,PARACLINICAL CHARACTERISTICS AND TREATMENT OF OVARIAN FIBROMA-THECOMA GROUPS AT VIETNAM NATIONAL CANCER HOSPITAL. Vietnam Medical Journal, 521(2). https://doi.org/10.51298/vmj.v521i2.4053

CLINICAL,PARACLINICAL CHARACTERISTICS AND TREATMENT OF OVARIAN FIBROMA-THECOMA GROUPS AT VIETNAM NATIONAL CANCER HOSPITAL

Thanh Đức Lê1,, Thị Lý Linh Nguyễn2
1 National Cancer Hospital
2 Hanoi Medical University

Main Article Content

Abstract

Purpose: We aimed to assess the clinical, paraclinical features, and treatment strategy of ovarian thecoma-fibroma groups. Materials and Methods: Medical records of 43 casesdiagnosed ovarian fibromas, thecomas, or fibro-thecomas from 2016 through 2020 in Vietnam National Cancer Hospital were reviewed retrospectively. Results: Patients with mean age of 52.6±13.7 (range :16-81 years old) were reviewed, 62% of cases were postmenopausal. The mean diameter of tumor was 11.8 cm (range: 3.5-25cm). On ultrasonography, the majority of masses were solid and hypoechoic. Surgery was the main treatment, including: tumorectomy (27.9%), unilateral salpingo-oophorectomy (20.9%), bilateral salpingo-oophorectomy (25.6%), or a total hysterectomy and bilateral salpingo - oophorectomy (25.6%). Conclusion: Ovarian fibro-thecomas are uncommon, belong to benign sex cord-stromal tumors. These lesions often occur in postmenopausal patients. Surgery is the main treatment of this tumors.


Keywords: ovarian sex cord-stromal tumors, ovarian thecoma-fibroma groups, ovarian thecomas, ovarian fibromas.

Article Details

Keywords

ovarian sex cord-stromal tumors, ovarian thecoma-fibroma groups, ovarian thecomas, ovarian fibromas.

References

1. Chi, Dennis S;Berchuck, Andrew; Dizon, Don S; Yashar, Catheryn M. Principle and practice of gynecologic oncology. Seventh ed; Wolters Kluwer; 2017; 1438-1486.
2. Chen H, Liu Y, Shen LF, Jiang MJ, Yang ZF, Fang GP. Ovarian thecoma-fibroma groups: clinical and sonographic features with pathological comparison. J Ovarian Res. 2016 Nov 22;9(1):81. doi: 10.1186/s13048-016-0291-2. PMID: 27876070; PMCID: PMC5120502.
3. Cho YJ, Lee HS, Kim JM, Joo KY, Kim ML. Clinical characteristics and surgical management options for ovarian fibroma/fibrothecoma: a study of 97 cases. Gynecol Obstet Invest. 2013;76(3):182–187.
4. Kurman RJCM, Herrington CS, Young RH. WHO classification of tumours of female reproductive organs. Bosman FTJE, Lakhani SR, Ohgaki H eds. Lyon: International Agency for Research on Cancer, 2014; 44-56.
5. Sivanesaratnam V, Dutta R, Jayalakshmi P. Ovarian fibroma--clinical and histopathological characteristics. Int J Gynaecol Obstet. 1990 Nov;33(3):243-7. doi: 10.1016/0020-7292(90)90009-a. PMID: 1977643.
6. Topalak O, Saygili U, Soyturk M, Karaca N, Batur Y, Uslu T, Erten O. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study. Gynecol Oncol. 2002 Apr;85(1):108-13. doi: 10.1006/gyno.2001.6575. PMID: 11925128.